Phase 1 clinical trials involve small groups of healthy volunteers to determine safety and side effects. Phase 2 trials enroll larger patient groups to study effectiveness and further monitor safety. Phase 3 trials involve even more patients to confirm effectiveness, monitor side effects, compare to standard treatments, and collect information to allow safe use. Post-marketing surveillance occurs after FDA approval to continue monitoring safety in large populations over long periods of time.